Online Medical Classes - Medical Transcription Companies News

Medical Transcription Companies News

MedQuist Pays Kaiser $2M to Settle Suit - cbl Wednesday, August 18, 2010 @ 10:22PMBy citybizlist StaffMOUNT LAUREL, N.J. -- MedQuist Inc. (NASDAQ: MEDQ), a medical transcription comp...
Medical Transcription Industry Association to change name to Clinical Documentation Industry Association Wednesday, August 18, 2010 @ 7:50AMProviding innovative solutions for EHR adoption that facilitate accurate and timely capture of health information continues to be a key message for the Medical Transcription Industry Association, whose members recently voted to change its name to Clinical Documentation Industry Association (CDIA) in an effort to reflect not only the expanded scope of services its members provide to the ...
Medical Transcription Industry Association Changes Name After 20 Years to Reflect Expanded Services in the Healthcare ... Wednesday, August 18, 2010 @ 6:09AMMODESTO, Calif.--(BUSINESS WIRE)--Providing innovative solutions for EHR adoption that facilitate accurate and timely capture of health information continues to be a key message for the Medical Transcription Industry Association, whose members recently voted to change its name to Clinical Documentation Industry Association (CDIA) in an effort to reflect not only the expanded scope of services ...
Oakton Community College briefs Thursday, August 5, 2010 @ 4:08AMStudents interested in pursuing a career in health care are invited to attend free information sessions in August at Oakton Community College, 1600 E. Golf Road, Des Plaines.
Press Release Monday, August 2, 2010 @ 10:34AMRegeneRx Biopharmaceuticals Inc. Posted on:02 Aug 10 RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) (â€œthe Companyâ€� or â€œRegeneRxâ€�) today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4 (TÃŸ4), is essential to healthy heart development and embryonic survival.
British Researchers Report that TB4 is Essential to Heart Development Monday, August 2, 2010 @ 7:43AMROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) (“the Company” or “RegeneRx”) today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4 (Tβ4), is essential to healthy heart development and embryonic survival. The research was conducted by Drs. Nicola Smart ...
British Researchers Report that TB4 is Essential to Heart Development Monday, August 2, 2010 @ 7:30AMROCKVILLE, Md.----RegeneRx Biopharmaceuticals, Inc. today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4 , is essential to healthy heart development and embryonic survival.
Regulate? Don't Regulate? Let's Do Both! Thursday, July 29, 2010 @ 9:55AMWill regulation of the direct-to-consumer genetic testing industry kill the personal genomics initiative, or will it protect consumers from companies with products of questionable value? To regulate or not to regulate has been the question on everyone's minds.
New Technology Solution Relieves Doctors of Time-Consuming Data Entry When Using EMRs, According to Emdat White Paper Wednesday, July 28, 2010 @ 5:35PMFITCHBURG, Wis.----A new method of populating electronic medical records that pulls patient information directly from a medical transcription enables physicians to keep their daily workflow the same, according to a white paper released today by Emdat, a provider of web-based medical transcription software.
Arsenic shows promise as cancer treatment, study finds Thursday, July 15, 2010 @ 1:32AMMiss Marple notwithstanding, arsenic might not be many people's favorite chemical. But the notorious poison does have some medical applications. Specifically, a form called arsenic trioxide has been used as a therapy for a particular type of leukemia for more than 10 years. Now researchers have shown that it may be useful in treating a variety of other cancers.
The Potential To Treat Cancer With Arsenic Tuesday, July 13, 2010 @ 10:13AMMiss Marple notwithstanding, arsenic might not be many people's favorite chemical. But the notorious poison does have some medical applications. Specifically, a form called arsenic trioxide has been used as a therapy for a particular type of leukemia for more than 10 years. Now researchers at the Stanford University School of Medicine have shown that it may be useful in treating a variety of ...
Research findings may help scientists understand how muscle and heart diseases develop Friday, July 9, 2010 @ 5:54AMResearchers from Mount Sinai School of Medicine have identified a previously unknown mechanism by which cells direct gene expression, the process by which information from a gene is used to direct the physical and behavioral development of individuals. The research, which may help scientists gain insight into how muscle and heart diseases develop, is published in the July 8th issue of Nature.
Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion ... Tuesday, June 29, 2010 @ 6:29AMReportlinker.com announces that a new market research report is available in its catalogue:
GeneGo Receives Phase II SBIR from NCI SBIR to Develop Integrative Cancer Data Analysis Platform Tuesday, June 22, 2010 @ 11:54AMGeneGo said today that it has been awarded a Phase II Small Business Innovation Research grant from the National Cancer Institute to continue the development of its MetaMiner (Oncology) platform.
GeneGo Gets NCI SBIR Grant for Translational Research Platform Tuesday, June 22, 2010 @ 9:24AMNEW YORK (GenomeWeb News) – GeneGo today said that the National Cancer Institute has awarded the firm a Phase II Small Business Innovation Research grant to fund further development of an analytical platform for translational research and data analysis in oncology.
Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State ... Thursday, June 17, 2010 @ 6:00AMKun Run Biotechnology, Inc. , a leading bio-pharmaceutical company in China focusing on manufacturing and sales of peptide-based and small molecule drugs, today announced that they have obtained the manufacturing approval for Entecavir from the China State Food and Drug Administration .
Orthopedic biomaterials market to grow at CAGR of 8.9% by 2016 Wednesday, May 26, 2010 @ 7:25AMResearch and Markets has announced the addition of the "U.S. Market for Orthopedic Biomaterials 2010" report to their offering.
MxSecure's Electronic Medical Record (EMR) Software, MxChart™, Now iPad Compatible Tuesday, May 25, 2010 @ 11:20AMMxSecure's electronic medical record (EMR) software, MxChart™ is now iPad compatible. Healthcare providers can now easily access critical patient information in MxChart EMR software wherever they are, via Apple iPad.
State OKs Affiliation Between Hartford, Central CT Hospital Tuesday, May 25, 2010 @ 5:00AMPlan Still Needs FTC Approval The state Office of Health Care Access has approved a proposed affiliation between the parent companies of Hartford Hospital and the Hospital of Central Connecticut, a key step toward a deal that would expand the reach of one of the state's major health care systems.
Quest Diagnostics Receives First FDA Clearance for H1N1 MDx Test Monday, May 24, 2010 @ 2:25PMNEW YORK (GenomeWeb News) – The US Food and Drug Administration today announced that Quest Diagnostics' Simplexa Influenza A H1N1 test has received 510(k) clearance, making it the first test to receive clearance from the agency for the virus.
Sangamo BioSciences and Collaborators Present Data in Fifteen Presentations Highlighting Broad Therapeutic ... Monday, May 24, 2010 @ 6:11AMZFP Therapeutic Programs Include Traumatic Brain Injury, Oncology, Infectious Diseases and Regenerative Medicine Stem Cell Applications read more
Sangamo BioSciences and Collaborators Present Data in Fifteen Presentations Highlighting Broad Therapeutic ... Monday, May 24, 2010 @ 6:00AMSangamo BioSciences, Inc. announced today that data from research and preclinical programs focused on the development of zinc finger DNA-binding protein Therapeuticsâ¢ were described in fifteen presentations given by Sangamo scientists and collaborators at the 13th Annual Meeting of the American Society of Gene and Cell Therapy . Â The meeting was held in Washington, DC from May 17-22, 2010.
Researchers Find Gene They Believe Is Key to Kidney Cancer Thursday, May 20, 2010 @ 1:42PMResearchers at Mayo Clinic's campus in Florida have discovered a key gene that, when turned off, promotes the development of common kidney cancer. Their findings suggest that a combination of agents now being tested in other cancers may turn the gene back on, providing a much-needed therapy for the difficult-to-treat cancer.
MEDRAD's Intego PET Infusion System integrated with Pinestar's Nuclear Medicine Information System Thursday, May 20, 2010 @ 3:07AMToday, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Intego™ PET Infusion System and Pinestar's Nuclear Medicine Information System (NMIS). The companies are closing the information gap between state of the art infusion systems and the latest information systems, and thus adding to the workflow benefits of automated FDG infusion.
MEDRAD and Pinestar Announce Data Integration to Enhance Workflow Benefits in PET Imaging Wednesday, May 19, 2010 @ 9:54AMread more
MEDRAD and Pinestar Announce Data Integration to Enhance Workflow Benefits in PET Imaging Wednesday, May 19, 2010 @ 9:46AMToday, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Integoâ¢ PET Infusion System and Pinestar's Nuclear Medicine Information System . Â The companies are closing the information gap between state of the art infusion systems and the latest information systems, and thus adding to the workflow benefits of automated FDG infusion. Â The data ...
Public Disclosure of FDA Panel Members' Conflicts of Interest Friday, April 23, 2010 @ 11:08AMThe Scientist reports that the FDA is changing its conflict-of-interest policy . In the past, if they wanted an interest waiver, the members of the organization's 32 advisory panels and committees would simply have to tell the FDA if they had any connections with a company that had a drug or medical device under FDA review, or with one of its competitors.
MedQuist Announces Completion of Spheris Transaction Friday, April 23, 2010 @ 9:13AMMedQuist Inc. , a leading provider of technology-enabled clinical documentation services, today announces that it has completed the purchase of the domestic business of Spheris Inc. Â Simultaneously, CBay Inc., MedQuist's majority owner, has acquired the stock of Spheris India Private Limited, a subsidiary of Spheris. Â Together, the combined companies will offer unprecedented opportunities for ...
Researchers discover and characterize general mechanism controlling transcription elongation in bacteria Friday, April 23, 2010 @ 8:02AMResearchers from NYU Langone Medical Center have discovered and characterized a general mechanism that controls transcription elongation in bacteria. The mechanism, described in the April 23 issue of Science, relies on physical cooperation between a moving ribosome and RNA polymerase (RNAP) that allows for a precise adjustment of the transcriptional yield in response to translational needs. The ...
EpiCept announces U.K. launch of Ceplene Monday, April 19, 2010 @ 11:48PMEpiCept Corporation today announced that the commercial launch of Ceplene® (histamine dihydrochloride) will take place in the United Kingdom on April 20, 2010 in conjunction with the British Society for Haematology 50th Annual Scientific Meeting in Edinburgh, Scotland. Ceplene is approved in the European Union for the remission maintenance and prevention of relapse in patients with Acute Myeloid ...
Consolidation in Medical Services Sector Tuesday, April 13, 2010 @ 10:03AMThe small cap development I’m watching today is in the technology sector. And more specifically, I’m looking at medical transcription companies...
AssistMed, Inc. and HealthPac Computer Systems, Inc. Announce Integration of AssistMed Duet(TM) and HPlus Pro(TM) Tuesday, April 13, 2010 @ 7:00AMLOS ANGELES and SAVANNAH, Ga. -- AssistMed, Inc. and HealthPac Computer Systems, Inc. today announced the integration of AssistMed's Duet data capture technology with HealthPac's HPlus Pro patient accounting and control system to enhance professional healthcare services.
City eyes chat nursing potentials for BPO Friday, April 9, 2010 @ 10:11AMA BOOMING industry in the United States' business processing sector is being eyed by local ICT players as a potential industry for Davao City that would benefit local nurses and nursing graduates. read more
Sangamo BioSciences Appoints Dr. Stephen G. Dilly to Its Board of Directors Thursday, April 1, 2010 @ 6:00AMSangamo BioSciences, Inc. , a leader in the research and development of novel zinc finger DNA-binding proteins for therapeutic gene regulation and modification, announced today the appointment of Stephen G.
Nuance announces medical dictation apps, SDK Monday, March 1, 2010 @ 12:59PMNuance Communications announced on Monday a series of smartphone applications and an SDK based on its popular Dragon NaturallySpeaking recognition technology.
Small-Cap Tech Stocks With Big Potential Monday, March 1, 2010 @ 8:46AMThese three small-cap stocks have trounced indices during the past year.
Nuance Extends Power and Experience of Mobile, Voice-Enabled Documentation and Search to the Healthcare Industry ... Monday, March 1, 2010 @ 7:00AMATLANTA----Nuance Communications, Inc., today announced it will showcase an advanced suite of Dragon Medical Mobile technologies and solutions at HIMSS. Building upon the recent success of its Dragon Dictation and Dragon Search consumer apps for the iPhone, which are powered by world-renowned Dragon NaturallySpeaking software, Nuance will extend its mobile speech technologies to the healthcare ...
Scribe Debuts VERSUS Front-End Speech at HIMSS Monday, March 1, 2010 @ 2:08AMFollowing on the heals of Scribe’s successful launch of the M*Modal Speech Understanding Engine as the first purely Web-native offering, Scribe is announcing the launch of VERSUS (Voice Enabled Recording and Speech Understanding System) (PRWeb Mar 1, 2010) Read the full story at http://www.prweb.com/releases/2010/03/prweb3663854.htm
AssistMed's Patient Adherence Solutions Selected by US Bioservices Thursday, February 11, 2010 @ 7:30AMLOS ANGELES -- AssistMed, Inc. today announced it has executed an agreement with US Bioservices, a business unit of AmerisourceBergen Specialty Group, to implement AssistMed's Patient Adherence and Disease Management Solutions.
PHNS Implements New Accelerated Claims Resolution Services With iSoftStone Wednesday, February 10, 2010 @ 2:13AMDALLAS and BEIJING, Feb. 9 /PRNewswire-Asia/ -- PHNS Inc. announced its new "24/7 Claims Acceleration" services for U.S.
PHNS Implements New Accelerated Claims Resolution Services With iSoftStone Tuesday, February 9, 2010 @ 9:41PMDALLAS and BEIJING, February 10 /PRNewswire/ -- - The strategic partnership brings PHNS' U.S. healthcare outsourcing and process improvement expertise together with iSoftStone, a leading China-based outsourcing provider PHNS Inc. announced its new "24/7 Claims Acceleration" services for U.S. hospitals using a team of Chinese business analysts trained by PHNS and China-based IT and business ...
PHNS Implements New Accelerated Claims Resolution Services With iSoftStone Tuesday, February 9, 2010 @ 9:07PMPHNS Inc. announced its new "24/7 Claims Acceleration" services for U.S. hospitals using a team of Chinese business analysts trained by PHNS and China-based IT and business process outsourcing provider iSoftStone.
Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician ... Tuesday, February 9, 2010 @ 8:35AMMxChart™, Speech Recognition and Stimulus Resource Library featured on redesigned MxSecure, Inc. site: www.mxsecure.com.
PHNS Implements New Accelerated Claims Resolution Services with iSoftStone Tuesday, February 9, 2010 @ 7:54AMDALLAS & BEIJING----PHNS Inc. announced its new “24/7 Claims Acceleration” services for U.S. hospitals using a team of Chinese business analysts trained by PHNS and China-based IT and business process outsourcing provider iSoftStone.
LabCorp Pens Cancer Dx-Development Deal With CancerGuide Diagnostics Thursday, February 4, 2010 @ 10:35AMAccording to CancerGuide, its initial tests will be designed to help physicians assess the risk of cancer recurrence and for therapy selection.
Into the Personal Genomics Fray Monday, January 25, 2010 @ 11:00AMCounsyl, a Stanford University start-up, has announced its Universal Genetic Test that allows prospective parents to determine whether their child would be at risk for more than 100 genetic diseases.
Sangamo BioSciences Announces Presentation Of Preliminary Data From Phase 1 Safety Trial Of SB-728-T For HIV/AIDS Wednesday, January 20, 2010 @ 7:44AMSangamo BioSciences, Inc. (Nasdaq: SGMO) announced that preliminary data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were presented on Friday, January 15, 2010 at the Keystone Symposium Session "HIV Biology and Pathogenesis." Sangamo's collaborator, Carl June, M.D...
Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium Wednesday, January 20, 2010 @ 12:10AMAlnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR ...
Webmedx Receives Best in KLAS Award for Outsourced Transcription for 2009 Tuesday, January 5, 2010 @ 7:10PMA first-time entrant into the annual survey, Webmedx achieved the highest overall performance ranking ever for their professional services category, 91.2% Overall Performance, according to the transcription services specialty report.
Webmedx Receives Best in KLAS Award for Outsourced Transcription for 2009 Tuesday, January 5, 2010 @ 3:48PMWebmedx, the fourth largest medical transcription service provider in the U.S. and the only leading company to employ a 100% domestic workforce, today announced it has received the Best in KLAS Award for Outsourced Transcription in the 2009 Top 20 Best in KLAS Awards: Software & Professional Services report.